0001209191-21-014690.txt : 20210226
0001209191-21-014690.hdr.sgml : 20210226
20210226160707
ACCESSION NUMBER: 0001209191-21-014690
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210224
FILED AS OF DATE: 20210226
DATE AS OF CHANGE: 20210226
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Arbuckle Stuart A
CENTRAL INDEX KEY: 0001557290
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 21688757
MAIL ADDRESS:
STREET 1: VERTEX PHARMACEUTICALS INCORPORATED
STREET 2: 130 WAVERLY ST.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-02-24
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001557290
Arbuckle Stuart A
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
EVP, Chief Commercial Officer
Common Stock
2021-02-24
4
F
0
2898
217.57
D
44737
D
Common Stock
2021-02-25
4
S
0
380
211.39
D
44357
D
Common Stock
2021-02-25
4
S
0
900
212.52
D
43457
D
Common Stock
2021-02-25
4
S
0
1400
213.55
D
42057
D
Common Stock
2021-02-25
4
S
0
400
214.32
D
41657
D
Common Stock
2021-02-25
4
S
0
300
215.62
D
41357
D
Common Stock
2021-02-25
4
S
0
254
216.57
D
41103
D
Common Stock
140
I
401(k)
Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $211.39 (range $210.76 to $211.68).
Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $212.52 (range $212.05 to $213.02).
Open market sales reported on this line occurred at a weighted average price of $213.55 (range $213.09 to $214.08).
Open market sales reported on this line occurred at a weighted average price of $214.32 (range $214.10 to $214.62).
Open market sales reported on this line occurred at a weighted average price of $215.62 (range $215.37 to $215.84).
Open market sales reported on this line occurred at a weighted average price of $216.57 (range $216.50 to $216.62).
/s/ Sabrina Yohai, Attorney-in-Fact
2021-02-26